Here I propose two grand challenges for medicinal chemists: the deorphanization of orphan GPCRs via in silico methods and the design of multitarget drugs with enhanced safety and efficacy over current medications.
Keywords:
In silico screening; deorphanization; GPCR; obesity; polypharmacology